Answer
Tafamidis meglumine may interact with methotrexate or imatinib through BCRP inhibition demonstrated in vitro; OAT1/OAT3 inhibition is not expected to cause clinically significant interactions at the 20 mg tafamidis meglumine dose.
Sources for this answer
- Vyndaqel 20 mg soft capsulesPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 18Document updated
Sources checked